Back
The RMR Group, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
31
RMR
The RMR Group, Inc.
Last Price:
$15.79
Seasonality Move:
-3.37%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$90.12
Seasonality Move:
10.35%
Sell
31
The RMR Group, Inc. (RMR)
is a Sell
Is The RMR Group, Inc. a Buy, Sell or Hold?
-
The current The RMR Group, Inc. [RMR] share price is $15.73. The Score for RMR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
RMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RMR Stock Price Chart
What is The RMR Group, Inc.'s stock price today?
-
The The RMR Group, Inc. share price today is $15.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $87.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
RMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 57.02 | Buy |
| Chaikin Money Flow: | 103377 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.12 - 15.68) | Buy |
| Bollinger Bands (100): | (15.1 - 16.62) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.53 | Buy |
| Relative Strength Index (14 RSI): | 71.11 | Buy |
| Chaikin Money Flow: | -592960 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.18 - 78.14) | Buy |
| Bollinger Bands (100): | (43.11 - 66.09) | Buy |
RMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.45 | Buy |
| 20-day SMA: | 15.33 | Buy |
| 50-day SMA: | 15.22 | Buy |
| 200-day SMA: | 15.99 | Sell |
| 8-day EMA: | 15.46 | Buy |
| 20-day EMA: | 15.38 | Buy |
| 50-day EMA: | 15.45 | Buy |
| 200-day EMA: | 16.69 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.75 | Buy |
| 20-day SMA: | 70.43 | Buy |
| 50-day SMA: | 63.87 | Buy |
| 200-day SMA: | 45.05 | Buy |
| 8-day EMA: | 80.77 | Buy |
| 20-day EMA: | 72.92 | Buy |
| 50-day EMA: | 64.9 | Buy |
| 200-day EMA: | 50.57 | Buy |
The RMR Group, Inc. Earnings Growth & RMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.32 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.
The RMR Group, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||